Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

Challenging scenarios in NSTEMI

16 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions that explore complex and challenging scenarios encountered in the management of NSTEMI patients. Participants will delve into discussions on topics such as coronary artery aneurysm, restenosis of coronary ostial stents, right-sided chest pain, subsequent occlusions of the left anterior...

Challenging scenarios in NSTEMI

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

16 May 2024 – From EuroPCR 2024

Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

Restoring vessel physiology drives outcomes - The Bioadaptor experience

16 May 2024 – From EuroPCR 2024

Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...

Restoring vessel physiology drives outcomes - The Bioadaptor experience

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

16 May 2024 – From EuroPCR 2024

This session presents the first results of randomized trials investigating the use of advanced plaque modification techniques, such as rotational atherectomy, lithotripsy, and laser atherectomy, as well as the role of intracoronary imaging (OCT and IVUS) in guiding percutaneous coronary intervention (PCI). The session aims to...

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

Drug-coated balloons in de novo coronary artery disease

16 May 2024 – From EuroPCR 2024

This session, in collaboration with various cardiology societies, focuses on the use of drug-coated balloons (DCBs) in the treatment of de novo coronary artery disease. It covers the optimal technique for PCI with DCBs, the indications and use of DCBs in small vessels, bifurcations, and multivessel...

Drug-coated balloons in de novo coronary artery disease

Stent loss and coronary perforation: how to deal with

16 May 2024 – From EuroPCR 2024

This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...

Stent loss and coronary perforation: how to deal with

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire

16 May 2024 – From EuroPCR 2024

Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guide

Other coronary interventions: SSO2, angioPy & more

16 May 2024 – From EuroPCR 2024

This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....

Other coronary interventions: SSO2, angioPy & more

PCI complications: mistakes in stent placement, stent elongation during implantation & more

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focusing on various PCI complications, including mistakes in stent placement, stent elongation during implantation, and unexpected stent behavior after post-dilatation. The cases are presented with interactive discussions to enhance understanding of these complex scenarios and their management.

PCI complications: mistakes in stent placement, stent elongation during implantation & more